Kidney Stone Market Growth Forecast: Rising Demand for Urological Treatments

Author : Sameer Straits2 | Published On : 01 Oct 2026

The global kidney stone market is evolving as healthcare providers expand access to advanced diagnostic technologies and minimally invasive treatment procedures. Kidney stones, also known as renal calculi, are hard mineral deposits that form in the kidneys and can cause significant discomfort and urinary complications. Growing demand for effective stone removal, early diagnosis, and improved patient recovery is supporting the development of specialized urological devices and treatment solutions.

According to Straits Research, the kidney stone market was valued at USD 2.84 billion in 2025 and is projected to grow from USD 2.96 billion in 2026 to USD 4.15 billion by 2034, registering a CAGR of 4.3% during the forecast period 2026–2034. North America held the largest regional market share in 2025, while Asia-Pacific is projected to experience the fastest growth.

Rising Kidney Stone Incidence Supports Market Growth

The prevalence of kidney stone disease, combined with demand for effective treatment, is supporting kidney stone market growth. Factors such as inadequate fluid intake, dietary habits, obesity, and metabolic disorders can contribute to stone formation. As healthcare providers focus on timely diagnosis and appropriate intervention, demand for imaging systems, stone removal devices, and specialized urological procedures continues to expand.

The market also benefits from advances in clinical management that help healthcare professionals select treatments according to stone size, composition, and location. Hospitals and urology centers use a combination of medication, lithotripsy, ureteroscopy, and other procedures to manage different cases. This range of treatment options supports demand for specialized medical equipment and related technologies.

Minimally Invasive Procedures Shape Market Trends

Minimally invasive treatment is a significant influence on kidney stone market trends. Ureteroscopy enables clinicians to access stones through the urinary tract, while extracorporeal shock wave lithotripsy (ESWL) uses shock waves to break stones into smaller fragments. These approaches offer alternatives to more invasive procedures, with treatment selection depending on the patient's condition and clinical assessment.

Straits Research projects that ureteroscopy will be the fastest-growing treatment segment, with a CAGR of 7.26% during 2026–2034. Adoption is supported by its minimally invasive nature, stone-removal effectiveness, and potential to reduce hospital stays and recovery time. Meanwhile, advances in endoscopic visualization, stone retrieval instruments, and lithotripsy systems are helping manufacturers strengthen their product portfolios.

Market Segmentation Highlights

The kidney stone market is segmented by stone type, treatment type, and diagnosis, reflecting the different clinical requirements involved in identifying and managing renal calculi.

The calcium oxalate stones segment accounted for a share of 58.3% in 2025, owing to the high prevalence of this stone type and its association with factors such as dietary habits, inadequate hydration, obesity, and metabolic disorders. Uric acid, struvite, cystine, and calcium phosphate stones also contribute to demand for diagnostic and treatment solutions.

By diagnosis, ultrasound accounted for 25.8% of the market in 2025, supported by its non-invasive nature, lack of radiation exposure, and relatively cost-effective use in detecting kidney stones. CT scans, X-rays, and intravenous pyelography also support diagnosis and treatment planning.

In treatment, ureteroscopy is expected to record the fastest growth, while medications, ESWL, and percutaneous nephrolithotomy remain important options for managing stones of different sizes and locations.

Download Full Report: https://straitsresearch.com/report/kidney-stone-market

Regional Analysis: North America Leads as Asia-Pacific Expands

North America dominated the kidney stone market in 2025, accounting for 38.4% of revenue, equivalent to USD 1.09 billion. The region benefits from established healthcare infrastructure, advanced diagnostic capabilities, and the adoption of minimally invasive urological procedures. The United States represented a market value of USD 940 million in 2025, while Canada reached USD 150 million.

Europe held 27.1% of the global market in 2025, valued at USD 770 million, with demand supported by advanced healthcare systems and the adoption of endoscopic procedures. Asia-Pacific accounted for 22.6%, equivalent to USD 640 million, and is projected to grow at a CAGR of 7.89% during 2026–2034. Improvements in healthcare infrastructure, growing awareness of kidney health, and increasing access to urological treatments are supporting the region's market outlook.

Competitive Landscape and Industry Developments

The competitive landscape includes medical technology companies supplying lithotripsy systems, ureteroscopes, stone retrieval devices, and diagnostic equipment. Key players identified by Straits Research include Boston Scientific Corporation, Siemens Healthcare GmbH, Cook Medical Inc., Dornier MedTech GmbH, Olympus Corporation, Stryker Corporation, Richard Wolf Medical Instruments Corporation, and DirexGroup.

Product innovation remains central to competition, with manufacturers focusing on procedural precision, visualization, and improved access to minimally invasive treatment. In April 2026, Olympus strengthened its urology portfolio with enhanced digital ureteroscopes and stone retrieval devices. In February 2026, Dornier MedTech expanded its lithotripsy offerings with ESWL systems featuring improved imaging guidance and treatment precision.

Challenges and Future Opportunities

The kidney stone market faces challenges associated with the cost of advanced medical equipment, the need for trained specialists, and differences in access to urological care. Healthcare facilities may also need to invest in equipment upgrades and supporting infrastructure to adopt newer technologies.

However, increasing demand for minimally invasive procedures and advances in endoscopic and lithotripsy technologies create opportunities for manufacturers. Continued improvements in diagnostic accuracy, stone retrieval, and procedural efficiency may support wider adoption across hospitals, specialty clinics, and other treatment settings.

Conclusion

The kidney stone market is projected to experience steady expansion through 2034, driven by demand for effective diagnosis and treatment. Calcium oxalate stones remain the leading stone-type segment, while ultrasound leads diagnostic applications and ureteroscopy is expected to record the fastest treatment-segment growth. Technology development and expanding access to minimally invasive care will continue to shape the market landscape.

About Straits Research

Straits Research is a market research and intelligence company that provides industry analysis, market forecasts, competitive assessments, and strategic insights to support business decision-making across global industries.